Welcome to our dedicated page for Maxlinear SEC filings (Ticker: MXL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MaxLinear, Inc.'s SEC filings document its public-company disclosures as a semiconductor issuer focused on RF, analog, digital and mixed-signal integrated circuits. Recent 8-K filings cover quarterly operating results, material agreements, credit-facility amendments, share repurchase authorization and governance changes.
Proxy materials describe board structure, director elections, committee service, executive compensation, equity awards and shareholder voting matters. The filing record also reflects capital-structure items tied to common stock, revolving credit arrangements, subsidiary participation in financing agreements and the risk and governance disclosures associated with MaxLinear’s operating business.
BEAVER CAROLYN reported acquisition or exercise transactions in this Form 4 filing.
MAXLINEAR, INC director Carolyn Beaver received a grant of 1,963 restricted stock units (RSUs). These RSUs give her the right to receive an equal number of MaxLinear common shares at vesting. Following the grant, she holds 1,963 RSUs directly.
The award vests in full if she continues serving as a director until the earlier of May 1, 2027, or the date immediately before the next annual stockholder meeting. No shares were bought or sold in the market; this is a stock-based compensation grant.
Company: MXL filed a Form 144 notice related to proposed sales of restricted common stock by an affiliate. The filing lists multiple restricted-stock allotments dated between 05/01/2017 and 05/01/2023 with individual share counts. It shows a sale during the past 3 months of 15,741 shares for $1,227,798.00 by Albert J. Moyer.
This notice is a regulatory filing that reports the seller, the class of security, grant dates, and recent dispositions; it does not state timing, price schedule, or whether additional shares will be sold under this notice.
MAXLINEAR, INC Chairman, President and CEO Kishore Seendripu reported routine equity compensation activity involving restricted stock units (RSUs). On May 20, 2026, RSUs covering 33,682 shares of Common Stock converted into 33,682 shares at a stated price of $0.00 per share.
To satisfy tax obligations on this vesting, 33,682 shares of Common Stock were withheld at $96.77 per share, a non-market tax-withholding disposition rather than an open-market sale. After these transactions, Seendripu directly held 924,083 shares of Common Stock and 132,400 RSUs. Various family, annuity, relatives and heritage trusts, plus a donor advised fund, also hold additional indirect positions in MaxLinear shares, where he or related parties serve as trustee, co-trustee or advisor, with certain trusts subject to Section 16 beneficial ownership disclaimers.
MaxLinear, Inc. reported results from its 2026 Annual Meeting of Stockholders. Shareholders approved amendments to the 2010 Equity Incentive Plan, adding 3,204,107 shares to the shares reserved and establishing a new ten-year term, and approved amendments to the 2010 Employee Stock Purchase Plan, extending its term and removing the automatic annual share increase. All proposals on the ballot passed, including the re-election of two Class II directors, an advisory vote approving 2025 named executive officer compensation, and ratification of Grant Thornton LLP as independent auditor. A total of 84,424,639 common shares, representing 94.3% of voting power as of the March 23, 2026 record date, were present or represented by proxy.
MAXLINEAR, INC corporate officer sells shares in open-market trades. Corporate Controller & Principal Accounting Officer Connie H. Kwong reported selling a total of 35,000 shares of MAXLINEAR common stock in two open-market transactions at prices around $96.92 and $97.15 per share. After these sales, she holds 42,408 shares directly. A footnote explains that 28,461 of the shares were sold at a weighted average price within a narrow range, indicating multiple executions within that band.
Morgan Stanley Smith Barney LLC Executive Financial Services filed a Form 144 regarding proposed sales of Common stock on NASDAQ. The filing lists recent dispositions by Connie Kwong: 04/27/2026 sale of 15,050 shares for $771,948.29 and 04/29/2026 sale of 4,118 shares for $238,844.00.
Morgan Stanley Smith Barney LLC Executive Financial Services filed a Rule 144 notice reporting proposed sales of 3,935 shares of Common Stock on 05/01/2026 classified as Restricted Stock. The filing also lists recent dispositions by Theodore Tewksbury: 3,935 shares sold for $304,411.60 on 05/04/2026 and 2,790 shares sold for $219,475.35 on 05/01/2026.
MaxLinear director Ted L. Tewksbury III reported a combination of equity vesting and stock sales in MaxLinear, Inc. common stock. On May 1, 2026, 15,741 restricted stock units (RSUs) fully vested, converting into the same number of common shares.
Between May 1 and May 5, 2026, he executed open-market sales totaling 10,660 shares at prices around $77–$80 per share. These transactions were carried out under a pre-arranged Rule 10b5-1 trading plan. After the reported trades, he directly holds 80,076 common shares of MaxLinear.
MaxLinear, Inc. director Kris Sennesael acquired 2,052 shares of Common Stock through RSU vesting. On May 1, 2026, 100% of a Restricted Stock Unit award vested, and each RSU converted into one share of MaxLinear Common Stock. Following this transaction, Sennesael directly holds 2,052 Common shares. The filing shows a routine compensation-related RSU vesting and derivative exercise with no open-market buying or selling.
MaxLinear director Carolyn Beaver reported an RSU vesting and partial share sale. On May 1, 2026, 15,741 restricted stock units converted into the same number of MaxLinear common shares, following 100% vesting of the award on that date.
On May 4, 2026, she completed an open‑market sale of 6,000 common shares at a weighted average price of $76.9578 per share, with individual trades between $76.95 and $77.03. After these transactions, Beaver directly holds 33,316 MaxLinear shares.